Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyaminopropyl biguanide (PAPB) is a synthetic polymer containing biguanide groups connected by propyl (three methylene units) linkers[4][5][2]. It is structurally a propyl analogue of polyhexamethylene biguanide (PHMB) but has significantly lower antibacterial activity compared to PHMB[4][7]. PAPB is mainly used as a preservative, disinfectant, or biocide in cosmetic and industrial applications, but its approval and use have been restricted in the EU and elsewhere due to toxicological safety concerns[2][4]. The chemical is often confused in regulatory and cosmetic databases with polyhexamethylene biguanide (PHMB), and many safety studies attributed to "polyaminopropyl biguanide" are actually based on PHMB[1]. There is no evidence that PAPB acts as a conventional therapeutic target such as a receptor, enzyme, transporter, or signaling protein. Its use is not linked to modulation of disease pathways, but rather to direct antimicrobial activity as a chemical biocide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyaminopropyl biguanide (PAPB).